Mayo Clinic, GE-backed startup secures $13.7M in Series A funding

Jessica Kim Cohen - Print  | 

San Francisco-based Vineti — a startup that leverages logistics, manufacturing and clinical data to improve patient access to cell and gene therapies — raised $13.75 million in Series A funding.

The funding included input from returning investors and cofounders GE Ventures and Mayo Clinic Ventures, along with new investments from DFJ and LifeForce Capital.

GE Ventures and Mayo Clinic Ventures launched the cloud-based Vineti platform to automate the production and delivery of individualized therapies. Vineti will use the Series A funding to grow its team and promote safety and regulatory compliance for cell therapies.

More articles on health IT:
How informatics led Dr. Don Rucker to head ONC
Health IT company CoPilot agrees to $130k settlement after delayed breach notification
DOD needs top talent to address cyberthreats, acting CIO says

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.